Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor.

Wang Y, Rabe KG, Bold MS, Shi M, Hanson CA, Schwager SM, Call TG, Kenderian SS, Muchtar E, Hayman SR, Koehler AB, Fonder AL, Chanan-Khan AA, Van Dyke DL, Slager SL, Kay NE, Ding W, Leis JF, Parikh SA.

Haematologica. 2020 Jan 23. pii: haematol.2019.240564. doi: 10.3324/haematol.2019.240564. [Epub ahead of print] No abstract available.

2.

Competency-Based Assessment of Interventional Cardiology Fellows' Abilities in Intracoronary Physiology and Imaging.

Flattery E, Rahim HM, Petrossian G, Shlofmitz E, Gkargkoulas F, Matsumura M, Kirtane AJ, Parikh SA, Parikh MA, Moses JW, Karmpaliotis D, Ben-Yehuda O, Leon MB, Jeremias A, Shlofmitz RA, Stone GW, Maehara A, Mahmud E, Mintz GS, Ali ZA.

Circ Cardiovasc Interv. 2020 Feb;13(2):e008760. doi: 10.1161/CIRCINTERVENTIONS.119.008760. Epub 2020 Jan 24. No abstract available.

PMID:
31973554
3.

Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis.

Kokkinidis DG, Arfaras-Melainis A, Giannopoulos S, Katsaros I, Jawaid O, Jonnalagadda AK, Parikh SA, Secemsky EA, Giri J, Kumbhani DJ, Armstrong EJ.

Vasc Med. 2020 Jan 22:1358863X19894055. doi: 10.1177/1358863X19894055. [Epub ahead of print]

PMID:
31964311
4.

Efficacy and safety of intravascular lithotripsy for the treatment of peripheral arterial disease: An individual patient-level pooled data analysis.

Madhavan MV, Shahim B, Mena-Hurtado C, Garcia L, Crowley A, Parikh SA.

Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28729. [Epub ahead of print]

PMID:
31957955
5.

Multiple B cell malignancies in patients with chronic lymphocytic leukemia: epidemiology, pathology, and clinical implications.

Parikh SA, Meacham PJ, Zent CS, Evans AG.

Leuk Lymphoma. 2020 Jan 11:1-15. doi: 10.1080/10428194.2019.1709830. [Epub ahead of print]

PMID:
31928278
6.

Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism.

Bikdeli B, Wang Y, Jimenez D, Ross JS, Gupta A, Desai MM, Parikh SA, Monreal M, Goldhaber SZ, Krumholz HM.

Thromb Res. 2020 Feb;186:78-79. doi: 10.1016/j.thromres.2019.12.020. Epub 2019 Dec 27. No abstract available.

PMID:
31901644
7.

Animal Product in Suture Material: A Survey Study of Dermatology Patient Perspectives.

Bentivegna K, DeWane ME, Parikh SA, Makkar HS, Finch J.

J Am Acad Dermatol. 2019 Dec 20. pii: S0190-9622(19)33302-X. doi: 10.1016/j.jaad.2019.12.025. [Epub ahead of print] No abstract available.

PMID:
31866265
8.

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

Hampel PJ, Call TG, Ding W, Muchtar E, Kenderian SS, Wang Y, Leis JF, Witzig TE, Koehler AB, Fonder AL, Schwager SM, Rabe KG, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA.

Am J Hematol. 2020 Mar;95(3):E57-E60. doi: 10.1002/ajh.25690. Epub 2019 Dec 13. No abstract available.

PMID:
31788844
9.

Acute pulmonary embolism unmasking underlying chronic thromboembolic pulmonary hypertension and iliac vein compression syndrome.

Brener MI, Green P, Parikh SA, Sethi SS.

Catheter Cardiovasc Interv. 2020 Feb 15;95(3):462-466. doi: 10.1002/ccd.28525. Epub 2019 Oct 8.

PMID:
31595624
10.

A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.

Cohen JA, Rossi FM, Zucchetto A, Bomben R, Terzi-di-Bergamo L, Rabe KG, Degan M, Steffan A, Polesel J, Santinelli E, Innocenti I, Cutrona G, D' Arena G, Pozzato G, Zaja F, Chiarenza A, Rossi D, Di Raimondo F, Laurenti L, Gentile M, Morabito F, Neri A, Ferrarini M, Fegan CD, Pepper CJ, Del Poeta G, Parikh SA, Kay NE, Gattei V.

Haematologica. 2019 Oct 3. pii: haematol.2019.228171. doi: 10.3324/haematol.2019.228171. [Epub ahead of print]

11.

Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years.

Gray WA, Jaff MR, Parikh SA, Ansel GM, Brodmann M, Krishnan P, Razavi MK, Vermassen F, Zeller T, White R, Ouriel K, Adelman MA, Lyden SP.

Circulation. 2019 Oct;140(14):1145-1155. doi: 10.1161/CIRCULATIONAHA.119.040518. Epub 2019 Sep 30.

12.

Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts.

Shishehbor MH, Schneider PA, Zeller T, Razavi MK, Laird JR, Wang H, Tieché C, Parikh SA, Iida O, Jaff MR.

J Vasc Surg. 2019 Oct;70(4):1177-1191.e9. doi: 10.1016/j.jvs.2019.02.030.

13.

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.

Abeykoon JP, Zanwar S, Ansell SM, Gertz MA, Kumar S, Manske M, Novak AJ, King R, Greipp P, Go R, Inwards D, Muchtar E, Habermann T, Witzig TE, Thompson CA, Dingli D, Lacy MQ, Leung N, Dispenzieri A, Gonsalves W, Warsame R, Kyle RA, Rajkumar V, Parikh SA, Kapoor P.

Br J Haematol. 2020 Feb;188(3):394-403. doi: 10.1111/bjh.16168. Epub 2019 Aug 29.

PMID:
31468508
14.

Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think Tank.

Naidu SS, Daniels MJ, Elmariah S, Garcia S, Klein AJ, Feldman DN, Ing FF, Kavinsky CJ, Devireddy C, Mahmud E, Grines CL, Henry TD, Duffy PL, Amin ZC, Aronow HD, Banerjee S, Brilakis ES, Herrmann HC, Hijazi ZM, Jaffer FA, Latif F, Messenger JC, Parikh SA, Poulin MF, Reilly JP, Rosenfield K, Szerlip M, Vincent RN, Cox DA; And the members of the SCAI 2019 Think Tank Consortium:, Baker D, Bhalla N, Bowen R, Camp C, Govender D, Haggstrom K, Hargus N, Hite D, Meikle J, Mylor B, Pierce V, Prince B, Roach J, Rudy J, Schludi B, Struck J, Tochterman A, Tolve M, William DM, Yowe S.

Catheter Cardiovasc Interv. 2019 Oct 1;94(4):598-606. doi: 10.1002/ccd.28449. Epub 2019 Aug 23. No abstract available.

PMID:
31441590
15.

Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics.

Tzafriri AR, Parikh SA, Edelman ER.

J Control Release. 2019 Sep 28;310:94-102. doi: 10.1016/j.jconrel.2019.08.019. Epub 2019 Aug 17.

PMID:
31430500
16.

Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015.

Bikdeli B, Wang Y, Jimenez D, Parikh SA, Monreal M, Goldhaber SZ, Krumholz HM.

JAMA. 2019 Aug 13;322(6):574-576. doi: 10.1001/jama.2019.8594. No abstract available.

17.

Clinical characteristics and outcomes of Richter transformation: Experience of 204 patients from a single center.

Wang Y, Tschautscher MA, Rabe KG, Call TG, Leis JF, Kenderian SS, Kay NE, Muchtar E, Van Dyke DL, Koehler AB, Schwager SM, Slager SL, Parikh SA, Ding W.

Haematologica. 2019 Jun 13. pii: haematol.2019.224121. doi: 10.3324/haematol.2019.224121. [Epub ahead of print]

18.

A Woman With Multiparity Experiencing Chest Pain in Her Early 60s.

Gaba P, Parikh SA, Collins MB.

JAMA Cardiol. 2019 Jul 1;4(7):710-711. doi: 10.1001/jamacardio.2018.4511. No abstract available.

PMID:
31188394
19.

Improved Interpretability of Machine Learning Model Using Unsupervised Clustering: Predicting Time to First Treatment in Chronic Lymphocytic Leukemia.

Chen D, Goyal G, Go RS, Parikh SA, Ngufor CG.

JCO Clin Cancer Inform. 2019 May;3:1-11. doi: 10.1200/CCI.18.00137.

20.

Ethical dilemma regarding more than one biopsy reimbursement.

Parikh SA, Grant-Kels JM.

J Am Acad Dermatol. 2019 Jun;80(6):1801-1803. doi: 10.1016/j.jaad.2017.08.008. Review. No abstract available.

PMID:
31103161
21.

Vascular Teams in Peripheral Vascular Disease.

Kolte D, Parikh SA, Piazza G, Shishehbor MH, Beckman JA, White CJ, Jaff MR, Iribarne A, Nguyen TC, Froehlich JB, Rosenfield K, Aronow HD; ACC Peripheral Vascular Disease Council.

J Am Coll Cardiol. 2019 May 21;73(19):2477-2486. doi: 10.1016/j.jacc.2019.03.463. Review.

PMID:
31097169
22.

Hemopericardium and Cardiac Tamponade as a Complication of Vena Caval Filters: Systematic Review of the Published Literature and the MAUDE Database.

Bikdeli B, Kirtane AJ, Jimenez D, Green P, Spencer FA, Kuo WT, Krumholz HM, Parikh SA.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619849111. doi: 10.1177/1076029619849111. No abstract available.

23.

Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies.

Peterson JF, Baughn LB, Ketterling RP, Pitel BA, Smoley SA, Vasmatzis G, Smadbeck JB, Greipp PT, Mangaonkar AA, Thompson CA, Parikh SA, Chen D, Viswanatha DS.

Blood Adv. 2019 Apr 23;3(8):1298-1302. doi: 10.1182/bloodadvances.2019031450. No abstract available.

24.

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

Hampel PJ, Ding W, Call TG, Rabe KG, Kenderian SS, Witzig TE, Muchtar E, Leis JF, Chanan-Khan AA, Koehler AB, Fonder AL, Schwager SM, Slager SL, Shanafelt TD, Kay NE, Parikh SA.

Leuk Lymphoma. 2019 Nov;60(11):2712-2719. doi: 10.1080/10428194.2019.1602268. Epub 2019 Apr 24.

PMID:
31014142
25.

Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.

Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group.

Haematologica. 2020 Jan 31;105(2):348-357. doi: 10.3324/haematol.2019.219626. Print 2020.

26.

Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension.

Sardar P, Bhatt DL, Kirtane AJ, Kennedy KF, Chatterjee S, Giri J, Soukas PA, White WB, Parikh SA, Aronow HD.

J Am Coll Cardiol. 2019 Apr 9;73(13):1633-1642. doi: 10.1016/j.jacc.2018.12.082.

PMID:
30947915
27.

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival.

Vendramini E, Bomben R, Pozzo F, Benedetti D, Bittolo T, Rossi FM, Dal Bo M, Rabe KG, Pozzato G, Zaja F, Chiarenza A, Di Raimondo F, Braggio E, Parikh SA, Kay NE, Shanafelt TD, Del Poeta G, Gattei V, Zucchetto A.

Leukemia. 2019 Aug;33(8):2111-2115. doi: 10.1038/s41375-019-0444-6. Epub 2019 Mar 14. No abstract available.

28.

Drug-Eluting Stent Implantation and Long-Term Survival Following Peripheral Artery Revascularization.

Secemsky EA, Kundi H, Weinberg I, Schermerhorn M, Beckman JA, Parikh SA, Jaff MR, Mustapha J, Rosenfield K, Yeh RW.

J Am Coll Cardiol. 2019 May 28;73(20):2636-2638. doi: 10.1016/j.jacc.2019.02.020. Epub 2019 Mar 1. No abstract available.

PMID:
30831175
29.

The Use of AngioVac Thrombectomy in IVC Filter-Associated IVC Thrombosis.

Saha A, Poterucha TJ, Parikh SA, Kirtane AJ, Sethi SS, Green P.

JACC Cardiovasc Interv. 2019 Mar 11;12(5):e41-e43. doi: 10.1016/j.jcin.2018.10.044. Epub 2019 Feb 13. No abstract available.

PMID:
30772292
30.

Transcatheter Cardiovascular Therapeutics 2018.

Mintz GS, Stone GW, Granada JF, Mehran R, Kirtane A, Dangas G, Parikh SA, Leon MB.

Eur Heart J. 2019 Feb 14;40(7):568-571. doi: 10.1093/eurheartj/ehy896. No abstract available.

PMID:
30768208
31.

Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices.

Secemsky EA, Kundi H, Weinberg I, Jaff MR, Krawisz A, Parikh SA, Beckman JA, Mustapha J, Rosenfield K, Yeh RW.

JAMA Cardiol. 2019 Apr 1;4(4):332-340. doi: 10.1001/jamacardio.2019.0325.

32.

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy.

Sinha S, Boysen JC, Chaffee KG, Kabat BF, Slager SL, Parikh SA, Secreto CR, Call T, Shanafelt TD, Leis JF, Warner SL, Bearss DJ, Ghosh AK, Kay NE.

Oncotarget. 2018 Dec 14;9(98):37173-37184. doi: 10.18632/oncotarget.26444. eCollection 2018 Dec 14.

33.

Strength of Evidence Underlying the American Heart Association/American College of Cardiology Guidelines on Endovascular and Surgical Treatment of Peripheral Vascular Disease.

Sardar P, Giri J, Jaff MR, Parikh SA, Kundu A, White CJ, Chatterjee S, Kennedy KF, Desai NR, Hyder ON, Mukherjee D, Shishehbor MH, Abbott JD, Aronow HD.

Circ Cardiovasc Interv. 2019 Jan;12(1):e007244. doi: 10.1161/CIRCINTERVENTIONS.118.007244.

PMID:
30608884
34.

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

Fang H, Reichard KK, Rabe KG, Hanson CA, Call TG, Ding W, Kenderian SS, Muchtar E, Schwager SM, Leis JF, Chanan-Khan AA, Slager SL, Braggio E, Smoley SA, Kay NE, Shanafelt TD, Van Dyke DL, Parikh SA.

Am J Hematol. 2019 Mar;94(3):338-345. doi: 10.1002/ajh.25385. Epub 2019 Jan 8.

PMID:
30575108
35.

ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine.

Bailey SR, Beckman JA, Dao TD, Misra S, Sobieszczyk PS, White CJ, Wann LS, Bailey SR, Dao T, Aronow HD, Fazel R, Gornik HL, Gray BH, Halperin JL, Hirsch AT, Jaff MR, Krishnamurthy V, Parikh SA, Reed AB, Shamoun F, Shugart RE, Yucel EK.

J Am Coll Cardiol. 2019 Jan 22;73(2):214-237. doi: 10.1016/j.jacc.2018.10.002. Epub 2018 Dec 17. No abstract available.

36.

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC.

N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1.

37.

SCAI 2018 Think Tank Proceedings: "What skillsets are required of vascular interventional cardiologists in evaluating and managing critical limb ischemia (CLI)? What role should SCAI play in supporting interventional cardiologists in their CLI practices, individually and collectively?"

Hawkins BM, Aronow HD, Parikh SA, Rosenfield K, Naidu SS; members of the SCAI 2018 Think Tank Consortium: Ellie Boutin, Fennel B, Fontenot K, Nicolosi M, Tieche C.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):511-513. doi: 10.1002/ccd.27900. Epub 2018 Nov 29.

PMID:
30489007
38.

Correction to: Decision Tree Based Classification of Abdominal Aortic Aneurysms Using Geometry Quantification Measures.

Parikh SA, Gomez R, Thirugnanasambandam M, Chauhan SS, De Oliveira V, Muluk SC, Eskandari MK, Finol EA.

Ann Biomed Eng. 2019 Jan;47(1):332. doi: 10.1007/s10439-018-02131-x.

PMID:
30377896
39.

Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry.

Bikdeli B, Lobo JL, Jiménez D, Green P, Fernández-Capitán C, Bura-Riviere A, Otero R, DiTullio MR, Galindo S, Ellis M, Parikh SA, Monreal M; RIETE Investigators.

J Am Heart Assoc. 2018 Sep 4;7(17):e009042. doi: 10.1161/JAHA.118.009042.

40.

Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.

Manso BA, Zhang H, Mikkelson MG, Gwin KA, Secreto CR, Ding W, Parikh SA, Kay NE, Medina KL.

Leukemia. 2019 Mar;33(3):638-652. doi: 10.1038/s41375-018-0280-0. Epub 2018 Oct 5.

41.

Have We Found the Right COMBO to Balance Vascular Injury and Healing?

Parikh SA.

JACC Cardiovasc Interv. 2018 Oct 8;11(19):1979-1981. doi: 10.1016/j.jcin.2018.05.037. No abstract available.

42.

Chronic lymphocytic leukemia treatment algorithm 2018.

Parikh SA.

Blood Cancer J. 2018 Oct 3;8(10):93. doi: 10.1038/s41408-018-0131-2. Review.

43.

Cryptococcus neoformans infections in patients with lymphoproliferative neoplasms.

Dioverti MV, Parikh SA, Osmon DR, Habermann TM, Tande AJ.

Leuk Lymphoma. 2019 Apr;60(4):920-926. doi: 10.1080/10428194.2018.1508666. Epub 2018 Sep 6.

PMID:
30188226
44.

Decision Tree Based Classification of Abdominal Aortic Aneurysms Using Geometry Quantification Measures.

Parikh SA, Gomez R, Thirugnanasambandam M, Chauhan SS, De Oliveira V, Muluk SC, Eskandari MK, Finol EA.

Ann Biomed Eng. 2018 Dec;46(12):2135-2147. doi: 10.1007/s10439-018-02116-w. Epub 2018 Aug 21. Erratum in: Ann Biomed Eng. 2018 Sep 18;:.

45.

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

Hampel PJ, Larson MC, Kabat B, Call TG, Ding W, Kenderian SS, Bowen D, Boysen J, Schwager SM, Leis JF, Chanan-Khan AA, Muchtar E, Hanson CA, Slager SL, Kay NE, Chaffee KG, Shanafelt TD, Parikh SA.

Br J Haematol. 2018 Nov;183(3):421-427. doi: 10.1111/bjh.15545. Epub 2018 Aug 16.

46.

A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses.

McCarter SJ, Vijayvargiya P, Sidana S, Nault AM, Lane CE, Lehman JS, Wilson JW, Parikh SA, Nowakowski GS, Al-Kali A.

Leuk Lymphoma. 2019 Feb;60(2):559-561. doi: 10.1080/10428194.2018.1494271. Epub 2018 Aug 2. No abstract available.

PMID:
30070153
47.

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.

Morabito F, Shanafelt TD, Gentile M, Reda G, Mauro FR, Rossi D, Di Renzo N, Molica S, Angrilli F, Chiarenza A, Cutrona G, Chaffee KG, Parikh SA, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Cortelezzi A, Gaidano G, Di Raimondo F, Fais F, Foà R, Neri A, Ferrarini M.

Am J Hematol. 2018 Sep;93(9):E216-E219. doi: 10.1002/ajh.25206. Epub 2018 Jul 30. No abstract available.

48.

PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.

He R, Ding W, Viswanatha DS, Chen D, Shi M, Van Dyke D, Tian S, Dao LN, Parikh SA, Shanafelt TD, Call TG, Ansell SM, Leis JF, Mai M, Hanson CA, Rech KL.

Am J Surg Pathol. 2018 Jul;42(7):843-854. doi: 10.1097/PAS.0000000000001077.

PMID:
29762141
49.

SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions.

Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ, Parikh SA, Prasad A, Rosenfield K, Shishehbor MH, Swaminathan RV, White CJ.

Catheter Cardiovasc Interv. 2018 Jul;92(1):124-140. doi: 10.1002/ccd.27635. Epub 2018 Apr 24. Review. No abstract available.

PMID:
29691970
50.

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.

Gentile M, Shanafelt TD, Reda G, Mauro FR, Zirlik K, Ciolli S, Laurenti L, Del Principe MI, Rossi D, Di Renzo N, Molica S, Angrilli F, Coscia M, Chiarenza A, Giordano A, Cutrona G, Chaffee KG, Parikh SA, Uccello G, Innocenti I, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Herishanu Y, Shvidel L, Tadmor T, Cortelezzi A, Del Poeta G, Gaidano G, Di Raimondo F, Neri A, Ferrarini M, Foà R, Polliack A, Morabito F.

Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20. No abstract available.

PMID:
29588545

Supplemental Content

Loading ...
Support Center